The largest database of trusted experimental protocols

6 protocols using cd117 pe cy7

1

CD44v6 Expression in AML Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
When the target cells were cell lines or T cells, incubation of the cells for 30 min was done with CD44v6‐PE (BD Bioscience, USA) or isotype control mouse IgG1‐PE (BD Bioscience, USA). When the target cells were peripheral blood mononuclear cells (PBMCs) from AML patients or healthy donors, the PBMCs were incubated with the following antibodies (BD Bioscience, USA): Fixable Viability Stain 510, CD117‐PE‐CY7, CD34‐APC, CD45‐APC‐CY7, HLA‐DR‐BV421, CD44v6‐PE or mouse IgG1‐PE. The samples were all detected by BD LSRFortessa X‐20 flow cytometry and analysed by FlowJo software.
+ Open protocol
+ Expand
2

Flow Cytometry Analysis of Virus-Infected Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flow cytometry was performed using direct fluorescence-conjugates and their respective controls. Phycoerythrin (PE)-labeled anti-human CD46 antibody and PE-labeled IgG1 isotype control were from eBioscience. CD117-PeCy7 and CD33-BV421 conjugates were from BD Biosciences. Dead cells were excluded using either 7-aminoactinomycin D (BioLegend) or using Fixable Aqua (Invitrogen; Thermo Fisher Scientific) following extracellular staining according to the manufacturer's instructions. Cells employed in the virus infection experiments were fixed using cytofix buffer (BD Biosciences). Acquisition was done using a Canto-II (BD Biosciences) or an Attune NxT (Life Technologies) cytometer. Viable, single cells were used for further analysis as depicted in Fig. S1 apart from tetramethylrhodamine ethyl ester (TMRE) staining where only subcellular debris was excluded.
+ Open protocol
+ Expand
3

Isolation and Analysis of Murine Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary splenocytes and thymocytes were recovered by crushing excised spleen or thymic tissue between glass microscope slides, washing with PBS + 2% FBS, and passing through an 80 µm mesh filter (Sefar, Nitex 03-80/37). Cells were washed once in PBS + 2% FBS and were resuspended in PBS + 2% FBS and kept on ice until analysis. For analysis of bone marrow, marrow was extracted from femurs using a mortar and pestle and processed as above. For analysis of peripheral blood, red blood cells were lysed (155 mM NH4CL, 12 mM NaHCO3, 0.13 mM EDTA) at room temperature and washed twice in PBS + 2% FBS. Flow cytometry analysis included a 4-color T-cell panel (CD8a-PE, CD4-APC, CD19-APC-Cy7and CD45r/B220-PerCP (BD Biosciences)) and a 6-color erythroid/myeloid panel (CD45-APC-Cy7, CD71-FITC, CD117-PE-Cy7, Ter119-APC, Ly-6G/Ly-6C (Gr1)-PerCP-Cy5.5, and B220-FITC (BD Biosciences) and CD3e Alexa Fluor 488 (BioLegend). Cells were also stained with DAPI to determine cell viability. Flow cytometry was performed on a Canto 2 (Becton Dickinson) or a custom designed LSR2 (Becton Dickinsin, Franklin Lakes, NJ) and analyzed using either FlowJo Software (FlowJo, Ashland, OR) or Woodlist, a noncommercial software program developed in our clinical laboratory52 (link).
+ Open protocol
+ Expand
4

Quantifying Cellular Marker Expression and Uptake

Check if the same lab product or an alternative is used in the 5 most similar protocols
The expression of cell surface markers was quantified by flow cytometric analysis. Stromal cells were labelled with antibodies CD29-APC, CD44-PerCP-Cy5.5, CD45-V500, CD73-PE, CD117-PE-Cy7, PerCP-Cy5.5 CD90 (BD Biosciences, San Jose, USA), and CD105-AlexaFluor488 (AbD Serotec, Oxford, UK). Respective isotype antibodies served as negative controls. A measurement of 3 × 104 events was carried out using BD FACS LSRII flow cytometer (BD Biosciences).
To evaluate miRNA and mRNA uptake efficiency, cells were treated with different amounts of Cy3-labeled Pre-miRNA Negative Control #1 (AM17120, Thermo Fisher) or GFP-mRNA (Trilink, San Diego, USA) and analyzed by flow cytometry 24 h post transfection. To detect cytotoxicity, cells were labelled with Near-IR LIVE/DEAD fixable dead cell stain kit (Molecular Probes, Eugene, USA). Analysis of flow cytometry data, including gating, was conducted with the FACSDiva software, Version 8. (Becton Dickinson).
+ Open protocol
+ Expand
5

Characterization of hMSC Surface Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell surface markers of freshly isolated and cultured CD105+ hMSCs were fluorescently labeled with anti-human antibodies CD29-APC, CD44-PerCP-Cy5.5, CD45-V500, CD73-PE, CD117-PE-Cy7 (BD Biosciences, Heidelberg, Germany), and CD105-AlexaFluor488 (AbD Serotec, Kidlington, UK). Respective mouse isotype antibodies served as negative controls. 3 × 104 events were acquired using BD FACS LSRII flow cytometer (BD Biosciences) and analyzed with BD FACSDiva Software 6 (BD Biosciences).
+ Open protocol
+ Expand
6

Clonogenic Assay for Hematopoietic Progenitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell morphology was assessed by staining cytospun cells with May-Gruenwald / Giemsa with the inclusion of o-dianidisine to identify haemaglobinised cells. The frequency of clonogenic cells, capable of continued self-renewal in high interleukin 3 was measured by seeding 1000 cells in 3 ml of methylcellulose self-renewal medium into each well of a 6-well plate [5, 6] .
Plates were incubated at 37 °C, 5% CO 2 in humidified air for 14 days before counting the number of visible colonies, all of which have undifferentiated morphology.
The following antibodies were used for FACS analysis: CD11b-APC (BioLegend); Ter-119-FITC (BioLegend); CD117-PE-Cy7 (BD Pharmingen) and anti-Sca-1-PE (BD Pharmingen).
FACS analysis was performed using a BD LSR II flow cytometer and BD FACSDiva Software, version 6.1.3.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!